Skip to Main Content

Paper Details

Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.
Ophthalmol Retina
10
2022
AMD, Neovascular Age-Related Macular Degeneration, Ranibizumab, age-related macular degeneration, drusen, intermediate AMD, nAMD, neovascular age-related macular degeneration, participants, patients, ranibizumab
Author NameAffiliation
Clement K ChanLoma Linda University
Wesley T BeaulieuJaeb Center for Health Research
Glenn YiuUniversity of California Davis Reading Center
  • 1 - 3

Datasets

Release 1.2